2m 2m 2m 2m 2m 2m 2m
CARDIFF ONCOLOGY (CRDF)
NASDAQ
$1.44+$0.04 (+3.14%)
Price as of Jun 03, 2026 7:57 PM EDT- $129.9MMarket Cap
- -61.33%1-Year Change
- BiotechnologyIndustry
CARDIFF ONCOLOGY (CRDF)
$1.44+$0.04 (+3.14%)
CRDF | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.40 | ||
Change | -$0.11 (-7.28%) | ||
Open | $1.50 | ||
High | $1.55 | ||
Low | $1.35 | ||
Previous Close | $1.51 | ||
Volume | 2,501,782 | ||
30-Day Average Volume | 1,431,495 | ||
1-Week Change | -22.65% | ||
1-Month Change | -18.13% | ||
1-Year Change | -61.33% | ||
3-Year Change | -14.11% | ||
5-Year Change | -81.65% | ||
Fundamentals | |||
Shares Outstanding | 68.4M | ||
Total Assets | $49.2M | ||
Market Cap | $129.9M | ||
Enterprise Value | $121.4M | ||
Period: QTR TTM FY | |||
Revenue | $41,000.00 | ||
Net Income | -$12.3M | ||
Free Cash Flow | -$12.3M | ||
EBIT | -$12.3M | ||
EBITDA | -$12.3M | ||
Net Working Capital | $32.9M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | 2,960 | ||
P/B | 4 | ||
P/E | -11 | ||
PEG | 0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 02/20/2019 | ||
Earnings & Revenue